vs

Side-by-side financial comparison of Dexcom (DXCM) and Occidental Petroleum (OXY). Click either name above to swap in a different company.

Occidental Petroleum is the larger business by last-quarter revenue ($1.7B vs $1.3B, roughly 1.3× Dexcom). Dexcom runs the higher net margin — 21.2% vs 6.9%, a 14.3% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -75.8%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -50.4%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Occidental Petroleum Corporation is an American company engaged in hydrocarbon exploration in the United States and the Middle East as well as petrochemical manufacturing in the United States, Canada, and Chile. It is incorporated under the Delaware General Corporation Law and headquartered in Houston. The company ranked 183rd on the 2021 Fortune 500 based on its 2020 revenues and 670th on the 2021 Forbes Global 2000.

DXCM vs OXY — Head-to-Head

Bigger by revenue
OXY
OXY
1.3× larger
OXY
$1.7B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+97.4% gap
DXCM
21.6%
-75.8%
OXY
Higher net margin
DXCM
DXCM
14.3% more per $
DXCM
21.2%
6.9%
OXY
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
-50.4%
OXY

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DXCM
DXCM
OXY
OXY
Revenue
$1.3B
$1.7B
Net Profit
$267.3M
$114.0M
Gross Margin
62.9%
Operating Margin
25.6%
-6.5%
Net Margin
21.2%
6.9%
Revenue YoY
21.6%
-75.8%
Net Profit YoY
153.6%
195.0%
EPS (diluted)
$0.67
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
OXY
OXY
Q1 26
$1.3B
Q4 25
$1.3B
$1.7B
Q3 25
$1.2B
$6.7B
Q2 25
$1.2B
$6.3B
Q1 25
$1.0B
$6.9B
Q4 24
$1.1B
$6.9B
Q3 24
$994.2M
$7.0B
Q2 24
$1.0B
$6.8B
Net Profit
DXCM
DXCM
OXY
OXY
Q1 26
$267.3M
Q4 25
$267.3M
$114.0M
Q3 25
$283.8M
$842.0M
Q2 25
$179.8M
$468.0M
Q1 25
$105.4M
$945.0M
Q4 24
$151.7M
$-120.0M
Q3 24
$134.6M
$1.1B
Q2 24
$143.5M
$1.2B
Gross Margin
DXCM
DXCM
OXY
OXY
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
87.8%
Q2 25
59.5%
86.6%
Q1 25
56.9%
88.4%
Q4 24
58.9%
89.0%
Q3 24
59.7%
88.5%
Q2 24
62.4%
87.9%
Operating Margin
DXCM
DXCM
OXY
OXY
Q1 26
25.6%
Q4 25
25.6%
-6.5%
Q3 25
20.1%
17.4%
Q2 25
18.4%
11.7%
Q1 25
12.9%
19.3%
Q4 24
17.0%
-2.5%
Q3 24
15.3%
22.7%
Q2 24
15.7%
24.0%
Net Margin
DXCM
DXCM
OXY
OXY
Q1 26
21.2%
Q4 25
21.2%
6.9%
Q3 25
23.5%
12.6%
Q2 25
15.5%
7.4%
Q1 25
10.2%
13.7%
Q4 24
13.6%
-1.7%
Q3 24
13.5%
16.2%
Q2 24
14.3%
17.2%
EPS (diluted)
DXCM
DXCM
OXY
OXY
Q1 26
$0.67
Q4 25
$0.67
$-0.07
Q3 25
$0.70
$0.65
Q2 25
$0.45
$0.26
Q1 25
$0.27
$0.77
Q4 24
$0.37
$-0.32
Q3 24
$0.34
$0.98
Q2 24
$0.35
$1.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
OXY
OXY
Cash + ST InvestmentsLiquidity on hand
$917.7M
$2.0B
Total DebtLower is stronger
$20.6B
Stockholders' EquityBook value
$2.7B
$36.0B
Total Assets
$6.3B
$84.2B
Debt / EquityLower = less leverage
0.57×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
OXY
OXY
Q1 26
$917.7M
Q4 25
$917.7M
$2.0B
Q3 25
$1.8B
$2.2B
Q2 25
$1.2B
$2.3B
Q1 25
$904.9M
$2.6B
Q4 24
$606.1M
$2.1B
Q3 24
$621.2M
$1.8B
Q2 24
$939.2M
$1.8B
Total Debt
DXCM
DXCM
OXY
OXY
Q1 26
Q4 25
$20.6B
Q3 25
$20.8B
Q2 25
$23.3B
Q1 25
$24.0B
Q4 24
$25.0B
Q3 24
$25.5B
Q2 24
$18.4B
Stockholders' Equity
DXCM
DXCM
OXY
OXY
Q1 26
$2.7B
Q4 25
$2.7B
$36.0B
Q3 25
$2.7B
$36.3B
Q2 25
$2.6B
$35.7B
Q1 25
$2.3B
$34.7B
Q4 24
$2.1B
$34.2B
Q3 24
$2.0B
$34.7B
Q2 24
$2.4B
$32.1B
Total Assets
DXCM
DXCM
OXY
OXY
Q1 26
$6.3B
Q4 25
$6.3B
$84.2B
Q3 25
$7.5B
$83.5B
Q2 25
$7.3B
$84.4B
Q1 25
$6.8B
$85.0B
Q4 24
$6.5B
$85.4B
Q3 24
$6.4B
$85.8B
Q2 24
$6.8B
$76.2B
Debt / Equity
DXCM
DXCM
OXY
OXY
Q1 26
Q4 25
0.57×
Q3 25
0.57×
Q2 25
0.65×
Q1 25
0.69×
Q4 24
0.73×
Q3 24
0.73×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
OXY
OXY
Operating Cash FlowLast quarter
$2.6B
Free Cash FlowOCF − Capex
$1.9B
FCF MarginFCF / Revenue
113.4%
Capex IntensityCapex / Revenue
45.4%
Cash ConversionOCF / Net Profit
23.11×
TTM Free Cash FlowTrailing 4 quarters
$4.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
OXY
OXY
Q1 26
Q4 25
$294.0M
$2.6B
Q3 25
$659.9M
$2.8B
Q2 25
$303.0M
$3.0B
Q1 25
$183.8M
$2.1B
Q4 24
$301.4M
$3.4B
Q3 24
$199.5M
$3.7B
Q2 24
$279.4M
$2.4B
Free Cash Flow
DXCM
DXCM
OXY
OXY
Q1 26
Q4 25
$192.1M
$1.9B
Q3 25
$579.4M
$1.0B
Q2 25
$208.9M
$962.0M
Q1 25
$96.8M
$240.0M
Q4 24
$176.8M
$1.6B
Q3 24
$88.3M
$2.0B
Q2 24
$213.3M
$623.0M
FCF Margin
DXCM
DXCM
OXY
OXY
Q1 26
Q4 25
15.3%
113.4%
Q3 25
47.9%
15.3%
Q2 25
18.1%
15.2%
Q1 25
9.3%
3.5%
Q4 24
15.9%
23.0%
Q3 24
8.9%
28.5%
Q2 24
21.2%
9.2%
Capex Intensity
DXCM
DXCM
OXY
OXY
Q1 26
Q4 25
8.1%
45.4%
Q3 25
6.7%
26.5%
Q2 25
8.1%
31.6%
Q1 25
8.4%
27.6%
Q4 24
11.2%
26.0%
Q3 24
11.2%
24.0%
Q2 24
6.6%
26.0%
Cash Conversion
DXCM
DXCM
OXY
OXY
Q1 26
Q4 25
1.10×
23.11×
Q3 25
2.33×
3.31×
Q2 25
1.69×
6.32×
Q1 25
1.74×
2.27×
Q4 24
1.99×
Q3 24
1.48×
3.23×
Q2 24
1.95×
2.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons